Pleurodesis

Pleurodesis is a medical procedure aimed at treating recurrent pleural effusions, which occur when excess fluid accumulates in the space between the membranes lining the lungs (the pleura). This condition can result from various underlying issues such as cancer, infections, or heart failure. During pleurodesis, a substance such as talc, doxycycline, or bleomycin is introduced into the pleural space through a chest tube. The chosen agent causes an inflammatory reaction between the layers of the pleura, leading them to stick together, effectively sealing the space and preventing further fluid buildup. This fusion reduces the recurrence of pleural effusions and can provide symptomatic relief for patients. The procedure is often considered when other treatments like draining the fluid (thoracentesis) or placing a drainage tube (chest tube) haven't provided lasting relief. Pleurodesis can be performed via thoracoscopy or thoracotomy, depending on the patient's condition and the underlying cause of the effusion. While pleurodesis can be an effective method to manage recurrent pleural effusions, it may carry risks such as pain, fever, or infection. Careful patient selection and monitoring are crucial to ensure the best outcomes post-procedure. This intervention aims to improve the patient's quality of life by reducing the need for repeated treatments for recurrent pleural effusions.